scispace - formally typeset
M

Michael Bachmann

Researcher at Helmholtz-Zentrum Dresden-Rossendorf

Publications -  402
Citations -  16252

Michael Bachmann is an academic researcher from Helmholtz-Zentrum Dresden-Rossendorf. The author has contributed to research in topics: Antigen & Chimeric antigen receptor. The author has an hindex of 63, co-authored 360 publications receiving 14388 citations. Previous affiliations of Michael Bachmann include ACADIA Pharmaceuticals Inc. & University of Southern California.

Papers
More filters
Journal ArticleDOI

Advances in In Vivo Bioluminescence Imaging of Gene Expression

TL;DR: In vivo bioluminescence imaging has been combined with in vivo fluorescence imaging methods, which has enabled the real-time study of immune cell trafficking, of various genetic regulatory elements in transgenic mice, and of in vivo gene transfer.
Journal ArticleDOI

MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer

TL;DR: It is reported that inactivation of the MYC oncogene is sufficient to induce sustained regression of invasive liver cancers and how oncogenic inactivation may reverse tumorigenesis in the most clinically difficult cancers is shown.
Journal ArticleDOI

Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells

TL;DR: Co-transduced T cells destroy tumors that express both antigens but do not affect tumors expressing either antigen alone, and this 'tumor-sensing' strategy may help broaden the applicability and avoid some of the side effects of targeted T-cell therapies.
Journal ArticleDOI

Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models

TL;DR: These metastatic cancer models, combined with noninvasive imaging techniques, constitute an integrated approach that could be applied to dissect the molecular mechanisms underlying the dissemination of metastatic CSCs (MCSCs) and to explore therapeutic strategies targeting MCSCs in general or to evaluate individual patient tumor cells and predict response to therapy.
Journal ArticleDOI

Differential fates of biomolecules delivered to target cells via extracellular vesicles

TL;DR: It is observed that only microvesicles (MVs) can functionally transfer loaded reporter molecules to recipient cells, largely by delivering plasmid DNA, and that exosomes and MVs are structurally and functionally distinct.